Stämm
PrivateLast Round
Series A
Mar 1, 2022
Total Funding Raised
$19.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Stämm is a biotechnology company that develops advanced biomanufacturing solutions, specializing in automated, continuous production processes for biologics, cell therapies, and emerging applications using microfluidics and 3D printing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stämm Comparables
Compare Stämm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astraveus | 82% | |
| Ori Biotech | 81% | |
| MFX | 80% |
Stämm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 1, 2022 | ||||
| Seed | Jun 27, 2019 | ||||
| Accelerator | Sep 20, 2018 | ||||
| Accelerator | Jul 25, 2018 |
Key People
Founding team and executive leadership
Stämm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VX Ventures | Series A |
| GRIDX | Series A |
| Varana Capital | Series A |
| Teramips Technologies | Series A |
| IndieBio | Accelerator |
| Draper Associates | Series A, Seed |
| Draper Cygnus | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 445% MoM, reaching 4.3K.
- Mar 12, 2026
Launched the High-Throughput Bioprocessor (HTB) for biomanufacturing.
Stämm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Stämm's valuation, stock price, and market status.
Is Stämm a public or private company?
Stämm is a private company.
What is the current stock price of Stämm?
Stämm is a private company with no public stock price. No recent secondary market data is available.
How much is Stämm worth (valuation)?
Valuation information for Stämm is not publicly available.
Can I buy Stämm stock?
Stämm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Stämm's last funding round?
Stämm's most recent funding round was Series A on March 1, 2022.
Who are the main investors in Stämm?
Key investors in Stämm include Varana Capital, IndieBio, Draper Associates.
Will Stämm IPO soon?
No public IPO plans have been announced for Stämm.
How can I track Stämm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stämm's secondary market activity and sign up for updates.